Are you Dr. Wheeler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 10 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 645
Rochester, NY 14642Phone+1 585-275-6177
Summary
- Dr. Thurman Wheeler, MD is a board certified neurologist in Rochester, New York. He is currently licensed to practice medicine in New York, Massachusetts, and California. He is affiliated with Massachusetts General Hospital and is an Assistant Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
Johns Hopkins UniversityFellowship, Clinical Neurophysiology, 1999 - 2000
University of WashingtonResidency, Neurology, 1996 - 1999- University of Washington School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2001 - Present
MA State Medical License 2013 - 2026
NY State Medical License 2005 - 2014- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy Start of enrollment: 2019 Nov 30
Publications & Presentations
PubMed
- 298 citationsReversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNAThurman M. Wheeler, Krzysztof Sobczak, John D. Lueck, Robert Osborne, Xiaoyan Lin
Science. 2009-07-17 - 60 citationsTargeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 MiceDominic Jauvin, Jessina Chrétien, Sanjay K. Pandey, Laurie Martineau, Lucille Revillod
Molecular Therapy. Nucleic Acids. 2017-06-16 - 372 citationsTargeting nuclear RNA for in vivo correction of myotonic dystrophyThurman M. Wheeler, Andrew Leger, Sanjay K. Pandey, A. Robert MacLeod, Masayuki Nakamori
Nature. 2012-08-02
Press Mentions
Fluorescence Light up Potential Antisense Oligo Drugs for MDJanuary 1st, 2019
Fluorescent Muscular Dystrophy Mouse Lights up Potential Antisense Oligo DrugsDecember 13th, 2018
New Mouse Model May Speed Identification of Promising Muscular Dystrophy TherapiesDecember 12th, 2018- Join now to see all
